dexamethasone cyclodextrin nanoparticle ophthalmic suspension (OCS-01) - Oculis
OCS-01: a Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery (clinicaltrials.gov) - Mar 18, 2025 - P3 | N=241 | Completed | Sponsor: Oculis | Recruiting ➔ Completed 
Trial completion • Cataract • Inflammation • Ocular Inflammation • Ophthalmology • Pain
http://clinicaltrials.gov/ct2/show/NCT05147233
 
Mar 18, 2025
 
Prev Next